REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Talis Biomedical Corp. (TLIS) on Tuesday reported a loss of $15.7 million in its third quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of $8.62.
The infectious disease diagnostics company posted revenue of $140,000 in the period.
Advertisement
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TLIS at https://www.zacks.com/ap/TLIS